Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report By Product, By Technique, By Application, By End-use, By Region, And Segment Forecasts, 2023 To 2030

The growth of the Antimicrobial Susceptibility Testing (AST) market can be attributed to the increasing incidence of infectious diseases, high antimicrobial resistance, and favorable government initiatives to decrease the burden of infectious diseases. Increasing cases of targeted diseases such as pneumonia & bloodstream infections caused by E.coli, K. pneumoniae, P. aeruginosa, and others are increasing the uptake of antimicrobial susceptibility tests. AST helps evaluate healthcare professionals' treatment options to manage infectious diseases. Moreover, increasing hospital-acquired and multi-drug resistant infections further propel the demand for antimicrobial susceptibility testing.

Government bodies are taking initiatives to combat resistance and increasing awareness about AMR among people. Favorable initiatives such as the Global Antimicrobial Resistance and Use Surveillance System (GLASS) provide annual analysis of AMR rates, testing coverage, trends, and systemic data on antimicrobial diseases in 27 countries. Moreover, in 2020, the U.S. updated the national action plan for Combating Antibiotic-Resistant Bacteria (CARB) to combat AMR infections and reduce antibiotic resistance in the next five years. Moreover, increasing penetration of personalized medicines and growing research activities to develop novel & effective treatments for infectious diseases are anticipated to boost the global demand for AST.

The market is segmented based on product, technique, application, end-use, and region. Manual tests, automated instruments, and consumables & media fall under the product segment. The technique segment is divided into automated AST, Etest method, dilution, disk diffusion, and others. The application segment is classified as drug development, susceptibility testing, and others. The end-use segment includes hospitals, diagnostic laboratories, biotechnology & pharmaceutical companies, and others.

The global antimicrobial susceptibility testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the overall market in 2022 and is anticipated to maintain its dominance throughout the forecast period. The increasing incidence of infectious diseases, increasing antimicrobial-resistant conditions, and the high number of research activities related to developing a novel treatment for infections in the region are expected to drive regional growth. For instance, more than 2.8 million AMR infections are registered yearly in the U.S. However, the Asia Pacific region is projected to grow at the fastest CAGR over the forecast period. Improving healthcare infrastructure, increasing research activities to develop novel therapeutics for infections, and government initiatives to reduce the disease burden are key factors driving regional market growth.

Antimicrobial Susceptibility Testing Market Segmentation

Key players operating in the antimicrobial susceptibility market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific Inc., BD, BIOMÉRIEUX, and Accelerate Diagnostics, Inc., among others. Market players adopt strategies such as new product launches and partnerships to increase their footprint in the global market. For instance, in January 2023, NanoSynex Ltd. announced its plan to commercialize its innovative rapid AST in 2023.